Search for: "Mylan Pharmaceuticals Incorporated"
Results 1 - 20
of 39
Sorted by Relevance
|
Sort by Date
12 Jun 2008, 4:45 am
By Donald Zuhn -- Yesterday, the Federal Circuit affirmed the determination by the District Court for the Southern District of New York that Defendants-Appellees Mylan Laboratories, Inc., Mylan Pharmaceuticals, Incorporated, Esteve Quimica, S.A., and Laboratorios Dr. [read post]
3 May 2016, 9:00 pm
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1] On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
3 May 2011, 7:16 am
Mylan Pharmaceuticals Inc. has lost its bid in Washington federal court to force a U.S. [read post]
10 Nov 2020, 2:01 am
Mylan Pharmaceuticals Inc. [read post]
1 Dec 2009, 9:45 am
Aeroflex Incorporated and Aeroflex Plainview Inc. [read post]
20 Sep 2017, 9:18 am
Mylan Pharmaceuticals Inc., a patent infringement matter brought under the Hatch-Waxman statute and filed before the TC Heartland decision, the parties did not dispute that, in light of TC Heartland, the defendant, a West Virginia corporation, could not be said to “reside” in Delaware. [read post]
8 Nov 2007, 9:00 pm
Due to popular demand, I will have a separate section for Pharmaceutical Industry items from this week. [read post]
3 Jun 2013, 1:30 am
June 12, 2013 - 2 PM: Mylan Inc. v. [read post]
1 Sep 2014, 7:04 am
. * Letter from AmeriKat: Judge Koh declares Takeda takes it too far with Mylan Dexilant declaration: The AmeriKat is back with a case review of Takeda Pharmaceutical Co., Ltd. et al v Mylan Inc. et al (here). [read post]
3 Oct 2022, 8:27 am
Mylan Pharmaceuticals Inc., No. 21-1567 [read post]
1 Jul 2022, 10:02 am
Mylan Pharmaceuticals Inc., No. 21-1567, also focuses on the written description requirement – asking what level of disclosure is necessary for a claim limitation requiring a therapeutic treatment to be “effective. [read post]
27 Sep 2009, 5:13 pm
We’ll have one final post tomorrow; included in today’s post are the Second Amendment incorporation petitions out of the Second and Seventh Circuits. [read post]
29 Jul 2013, 12:16 pm
Mylan Pharmaceuticals Inc. et al., C.A. [read post]
28 Sep 2016, 8:39 am
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Mylan Pharmaceuticals, et al. v. [read post]
5 Mar 2015, 5:52 am
Mylan Pharmaceutical, Inc., ___ F. [read post]
17 Mar 2020, 1:32 pm
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
24 Sep 2010, 1:15 pm
Mylan Labs, Inc., 520 F.3d 1358 (Fed. [read post]
1 Sep 2009, 4:39 am
In April, 2008, the FDA announced a recall of the drug Digitek® (Digoxin) distributed by Mylan Bertek Pharmaceuticals, Inc. and UDL Laboratories, Inc. [read post]
26 Sep 2022, 4:49 am
Mylan. [read post]
